Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 1092

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 1092
---
 ERISA
” means the Employee Retirement Income Security Act of 1974.

“

#### Exchange Act
” means the Securities Exchange Act of 1934.

“

#### Exchange Ratio
” means, subject to Section 1.5(f) , the following ratio (rounded to four decimal places): the quotient obtained by dividing (a) the Company Merger Shares by (b) the Company Outstanding Shares, in which:

•

“

#### Aggregate Convertible Note Valuation
” means the aggregate principal amount of the Bridge Notes plus all accrued and unpaid interest.

•

“

#### Aggregate Post-Bridge Valuation
” means the sum of (i) the Company Valuation, plus (ii) the Parent Valuation plus (iii) the Implied Note Valuation.

•

“

#### Aggregate Valuation
” means the sum of (i) the Company Valuation, plus (ii) the Parent Valuation plus (iii) the Aggregate Convertible Note Valuation.

•

“

#### Company Allocation Percentage
” means 1.00 minus the Parent Allocation Percentage.

•

“

#### Company Merger Shares
” means the Total Company Merger Shares less the Conversion Shares.

•

“

#### Company Valuation
” means $210,000,000.

•

“

#### Company Outstanding Shares
” means the total number of shares of Company Capital Stock outstanding immediately prior to the Effective Time, after giving effect to the Preferred Stock Conversion and excluding any Conversion Shares, expressed on a fully diluted and as-converted to Company Common Stock basis, expressed on a fully-diluted and as-converted to Company Common Stock basis and using the treasury stock method, but assuming, without limitation or duplication, (i) the exercise of all Company Options outstanding as of immediately prior to the Effective Time, and (ii) the issuance of shares of Company Capital Stock in respect of all other outstanding options, restricted stock awards, restricted stock units, warrants or rights to receive such shares, whether conditional or unconditional and including any outstanding options, warrants, restricted stock awards, restricted stock units or rights triggered by or associated with the consummation of the Merger (but excluding any shares of Company Capital Stock reserved for issuance other than with respect to outstanding Company Options under the Company Plan as of immediately prior to the Effective Time).

•

“

#### Conversion Shares
” means the product obtained by multiplying (a) the Post-Closing Parent Shares by (b) the quotient obtained by dividing (i) the Implied Note Valuation by (ii) the Aggregate Post-Bridge Valuation.

•

“